Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07784192Completed
Randomised, open-label trial of bupivacaine and morphine in postoperative pain, sponsored by Selçuk University. Primary endpoint: Cumulative intravenous morphine consumption at 24 hours. Started Aug 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07784192.